A 3-genes interferon signature predicts sustained complete remission in pediatric AML patients
Shimaa Sherif, Aesha I. Ali, Khadega Ibrahim, Darawan Rinchai, Mohammed Elanbari, Dhanya Kizhakayil, Mohammed Toufiq, Fazulur Rehaman Vempalli, Tommaso Mina, Patrizia Comoli, Kulsoom K. Ghias, Zehra Fadoo, Sheanna M Herrera, Che‐Ann Lachica, E. Dawoud, , Sara Deola
This paper identifies a three-gene interferon signature that predicts sustained remission in pediatric AML patients by stratifying chemosensitivity and survival outcomes.
bioRxiv · Jul 17, 2025 · PreprintCancer Biology